Communication Consulting Marketing Pharma SRL
Communication Consulting Marketing Pharma reported total assets of 266,810 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026).
The score of Communication Consulting Marketing Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +115 % Total assets +54 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Communication Consulting Marketing Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 41,600 € | ||||
| Equity | 262,283 € | ||||
| Cash | 89,313 € | ||||
| EBITDA | 70,660 € | ||||
| Total assets | 266,810 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 09 Jul 2025
- Year ended 31 Dec 2023filed on 27 Jun 2024
- Year ended 31 Dec 2022filed on 10 Jul 2023
- Year ended 31 Dec 2021filed on 19 Jun 2022
Communication Consulting Marketing Pharma's financial analysis
- Solvency98.3%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Communication Consulting Marketing Pharma
1 active director(s) in the register.
Communication Consulting Marketing Pharma's shareholders and holdings →Communication Consulting Marketing Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0475.754.613
- VAT number
- BE0475754613
- Peppol
- Registered · 0208:0475754613 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Oct 2001
- Registered office
- 1780 Wemmel
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Communication Consulting Marketing Pharma (SRL) has been based in Wemmel since 2001, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 41,600 € and equity of 262,283 €; its revenue is not published. Its solvency stands at 98.3%, above the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Communication Consulting Marketing Pharma
Companies in the same business, of comparable size and area, outside its group.
- Accuray Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet 257,954 €
- DJB Medical Wholesale of pharmaceutical and medical goods Merchtem · balance sheet 406,739 €
- AlphaCare Wholesale of pharmaceutical and medical goods Grez-Doiceau · balance sheet 559,557 €
- Xtrapharma Wholesale of pharmaceutical and medical goods Brussels · balance sheet €2.17m
- Laboratoires Bailleul Wholesale of pharmaceutical and medical goods Anderlecht · balance sheet €2.45m
- Henry Schein Wholesale of pharmaceutical and medical goods Vilvoorde · balance sheet €13.0m
- Logistic Care Wholesale of pharmaceutical and medical goods Wommelgem · balance sheet 224,218 €
- XMED Wholesale of pharmaceutical and medical goods Koksijde · balance sheet 136,494 €
Frequently asked questions about Communication Consulting Marketing Pharma
What is the revenue of Communication Consulting Marketing Pharma?
Communication Consulting Marketing Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Communication Consulting Marketing Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0475754613 for Communication Consulting Marketing Pharma, if the company is VAT-registered. Its company number (CBE) is 0475.754.613.
Where is the registered office of Communication Consulting Marketing Pharma?
According to the CBE register, the registered office of Communication Consulting Marketing Pharma is in 1780 Wemmel.
What is the equity of Communication Consulting Marketing Pharma?
At the close of the 2025 financial year, the equity of Communication Consulting Marketing Pharma amounts to 262,283 €, a solvency of 98.3% of total assets.
Who manages Communication Consulting Marketing Pharma?
The register lists 1 active mandates at Communication Consulting Marketing Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Communication Consulting Marketing Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →